Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00213928 · ClinicalTrials.gov registry record · Phase 2
Horse Chestnut Seed Extract for Lymphedema
A Phase 2 study of Lymphedema of Arm, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT00213928 is a Phase 2 study of Lymphedema of Arm that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 56 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00213928, a Phase 2 study of Lymphedema of Arm, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
To help Treat Lymphedema of the Arm in Breast Cancer Survivors with Horse chestnut Seed Extract
Conditions Studied
Interventions
- DRUG Horse Chestnut Seed Extract
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2002-05 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00213928
The ClinicalTrials.gov registry entry for NCT00213928 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphedema of Arm appearing as the primary indexed condition, and to 1 intervention - of which Horse Chestnut Seed Extract is the first listed.
NCT00213928 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00213928 about?
NCT00213928 is a clinical study titled "Horse Chestnut Seed Extract for Lymphedema". To help Treat Lymphedema of the Arm in Breast Cancer Survivors with Horse chestnut Seed Extract
What is the current status of trial NCT00213928?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2002-05. Estimated completion is 2008-09.
What conditions does trial NCT00213928 study?
This clinical trial studies the following conditions: Lymphedema of Arm.
What interventions are being tested in trial NCT00213928?
The interventions under investigation include: Horse Chestnut Seed Extract (DRUG).
Who is sponsoring clinical trial NCT00213928?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00213928 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.